Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M705200200 on July 10, 2007

J. Biol. Chem., Vol. 282, Issue 37, 26746-26753, September 14, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/37/26746    most recent
M705200200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Athanasopoulos, A. N.
Right arrow Articles by Chavakis, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Athanasopoulos, A. N.
Right arrow Articles by Chavakis, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Vascular Endothelial Growth Factor (VEGF)-induced Up-regulation of CCN1 in Osteoblasts Mediates Proangiogenic Activities in Endothelial Cells and Promotes Fracture Healing*

Athanasios N. Athanasopoulos{ddagger}1, Darius Schneider{ddagger}1, Tanja Keiper{ddagger}, Volker Alt§, Usha R. Pendurthi, Ute M. Liegibel{ddagger}, Ulrike Sommer{ddagger}, Peter P. Nawroth{ddagger}, Christian Kasperk{ddagger}, and Triantafyllos Chavakis{ddagger}||2

From the {ddagger}Department of Internal Medicine I, University Heidelberg, D-69120 Heidelberg, the §Department of Trauma Surgery, University Hospital Giessen-Marburg, D-35385 Giessen, Germany, the Biomedical Research Division, The University of Texas Health Center at Tyler, Tyler, Texas, and the ||Experimental Immunology Branch (EIB), NCI, National Institutes of Health, Bethesda, Maryland 20992

Angiogenesis is indispensable during fracture repair, and vascular endothelial growth factor (VEGF) is critical in this process. CCN1 (CYR61) is an extracellular matrix signaling molecule that has been implicated in neovascularization through its interactions with several endothelial integrin receptors. CCN1 has been shown to be up-regulated during the reparative phase of fracture healing; however, the role of CCN1 therein remains unclear. Here, the regulation of CCN1 expression in osteoblasts and the functional consequences thereof were studied. Stimulation of osteoblasts with VEGF resulted in a dose- and time-dependent up-regulation of CCN1 mRNA and protein. An up-regulation of both cell surface-associated CCN1 as well as extracellular matrix-associated CCN1 in osteoblasts was found. The supernatant of VEGF-prestimulated osteoblasts was chemotactic for endothelial cells, increasing their migration and stimulated capillary-like sprout formation. These effects could be attributed to the presence of CCN1 in the osteoblast supernatant as they were prevented by an antibody against CCN1 or by small interfering RNA-mediated knockdown of osteoblast CCN1. Moreover, the supernatant of VEGF-prestimulated osteoblasts induced angiogenesis in Matrigel plugs in vivo in a CCN1-dependent manner. In addition, blockade of CCN1 prevented bone fracture healing in mice. Taken together, the present work demonstrates a potential paracrine loop consisting of the VEGF-mediated up-regulation of CCN1 in osteoblasts that attracts endothelial cells and promotes angiogenesis. Such a loop could be operative during fracture healing.


Received for publication, June 25, 2007 , and in revised form, July 9, 2007.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Both authors contributed equally to the work.

2 To whom correspondence should be addressed: EIB, NCI, National Institutes of Health, 10 Center Dr., Rm. 4B17, Bethesda, MD 20892. Tel.: 301-451-2104; Fax: 301-496-0887; E-mail: chavakist{at}mail.nih.gov.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
IOVSHome page
J.-J. You, C.-H. Yang, M.-S. Chen, and C.-M. Yang
Cysteine-rich 61, a Member of the CCN Family, as a Factor Involved in the Pathogenesis of Proliferative Diabetic Retinopathy
Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3447 - 3455.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H.-W. Koon, D. Zhao, H. Xu, C. Bowe, A. Moss, M. P. Moyer, and C. Pothoulakis
Substance P-Mediated Expression of the Pro-Angiogenic Factor CCN1 Modulates the Course of Colitis
Am. J. Pathol., August 1, 2008; 173(2): 400 - 410.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement